Company intelligence / Profile preview
Oncostar
- Ownership
- Private
- Development stage
- Other
Overview
Oncostar encompasses two distinct entities: a Russian biotech startup in pre-clinical/early clinical development of recombinant oncolytic virus therapies for cancer, and Oncostar Pharma Private Limited, an Indian pharmaceutical wholesaler/distributor of generic oncology drugs at commercial stage.
- Therapeutic areas
- Oncology
- Modalities
- Recombinant oncolytic virus therapySmall molecule drugsCytotoxics
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Oncostar.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oncostar.